GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Gross Profit

Shire (SHPG) Gross Profit : $11,040 Mil (TTM As of Sep. 2018)


View and export this data going back to 1998. Start your Free Trial

What is Shire Gross Profit?

Shire's gross profit for the three months ended in Sep. 2018 was $2,714 Mil. Shire's gross profit for the trailing twelve months (TTM) ended in Sep. 2018 was $11,040 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Shire's gross profit for the three months ended in Sep. 2018 was $2,714 Mil. Shire's Revenue for the three months ended in Sep. 2018 was $3,872 Mil. Therefore, Shire's Gross Margin % for the quarter that ended in Sep. 2018 was 70.10%.

Shire had a gross margin of 70.10% for the quarter that ended in Sep. 2018 => Durable competitive advantage


Shire Gross Profit Historical Data

The historical data trend for Shire's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Gross Profit Chart

Shire Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,263.50 5,042.80 5,447.70 7,580.10 10,459.80

Shire Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,696.20 2,881.40 2,633.30 2,811.20 2,714.10

Competitive Comparison of Shire's Gross Profit

For the Biotechnology subindustry, Shire's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shire's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shire's Gross Profit distribution charts can be found below:

* The bar in red indicates where Shire's Gross Profit falls into.



Shire Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Shire's Gross Profit for the fiscal year that ended in Dec. 2017 is calculated as

Gross Profit (A: Dec. 2017 )=Revenue - Cost of Goods Sold
=15160.6 - 4700.8
=10,460

Shire's Gross Profit for the quarter that ended in Sep. 2018 is calculated as

Gross Profit (Q: Sep. 2018 )=Revenue - Cost of Goods Sold
=3871.7 - 1157.6
=2,714

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $11,040 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Shire's Gross Margin % for the quarter that ended in Sep. 2018 is calculated as

Gross Margin % (Q: Sep. 2018 )=Gross Profit (Q: Sep. 2018 ) / Revenue (Q: Sep. 2018 )
=(Revenue - Cost of Goods Sold) / Revenue
=2,714 / 3871.7
=70.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Shire  (NAS:SHPG) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Shire had a gross margin of 70.10% for the quarter that ended in Sep. 2018 => Durable competitive advantage


Shire Gross Profit Related Terms

Thank you for viewing the detailed overview of Shire's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Shire (SHPG) Business Description

Traded in Other Exchanges
N/A
Address
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
Executives
James H Cavanaugh director 265 HOTHORPE LANE, VILLANOVA PA 19085